IOL Chemicals Q4 Results: Stock ends 9% higher after revenue, margin growth

Shares of IOL Chemicals and Pharmaceuticals Ltd. gained nearly 6% on Wednesday, May 20, after the company reported its fourth quarter earnings.

The company reported a healthy set of results across all parameters in the March quarter.

Its net profit came in at ₹53.2 crore, up 69.2% from the previous year's ₹31.4 crore.

Its revenue increased 17.4% to ₹620 crore from ₹527.8 crore last year.

The company's earnings before interest, tax, depreciation and amortisation (EBITDA) increased 47.3% to ₹92.5 crore from ₹63 crore in the March quarter last year.

EBITDA margins expanded to 14.9% from 11.9% in the year-ago period.

IOL Chemicals is scheduled to hold its 39th annual general meeting (AGM) on September 2, 2026.

The company's board on Wednesday also approved the installation of a plant to manufacture a new product 'triacetin' and enhance the installed capacity of pantoprazole. Triacentin is a clear, colourless and slightly viscous oily liquid with diversified applications across the food, pharma, cosmetic and industrial sectors, the company said.

Shares of IOL Chemicals and Pharmaceuticals Ltd. were trading 8.7% higher at ₹119.6 apiece at 3pm on Wednesday. The stock has gained 36.36% in the past month and 45.5% this year, so far.

Also Read: Samvardhana Motherson Q4 Results: Stock rises 3% on Earnings beat, optimistic outlook